Key result
Residual trabeculation after LAAC is linked to higher procedural leak without affecting 3-year outcomes.
Why the study?
Research on the impact of angiographically detected residual trabeculation after left atrial appendage closure using the WATCHMAN device is limited.
Does angiographically detected residual trabeculation affect clinical outcomes or device-related complications in patients with atrial fibrillation undergoing LAAC?
Cohort (n=1,350)
Yes
Does angiographically detected residual trabeculation affect clinical outcomes or device-related complications in patients with atrial fibrillation undergoing LAAC?
Residual trabeculation after LAAC with the WATCHMAN device increases procedural peri-device leak but does not impact long-term leak, thrombosis, or clinical outcomes.
Answers are grounded in this paper and cite their sources.
Residual trabeculation after WATCHMAN LAAC increases peri-device leak without affecting 3-year outcomes; hypothesis-generating and should not yet change practice.
BACKGROUND: Research on the impact of angiographically detected residual trabeculation after left atrial appendage closure (LAAC) is limited. OBJECTIVES: To investigate the incidence, characteristics, and clinical implications of angiographically detected residual trabeculation after LAAC using the WATCHMAN device. METHODS: We analyzed 1350 consecutive patients with atrial fibrillation undergoing LAAC using the WATCHMAN device from the OCEAN-LAAC registry, which is a prospective ongoing, multicenter Japanese registry. The inclusion criteria comprised patients who successfully underwent LAAC and whose presence or absence of residual trabeculation can be confirmed using a contrast medium. The clinical outcomes were compared between patients with and without angiographically detected residual trabeculation. RESULTS: Residual trabeculation was angiographically detected in 5.6% (75/1350 patients). At the procedure, the proportion of peri-device leak (PDL) was significantly higher in the residual trabeculation group than in the non-residual trabeculation group (20% vs. 5.1%, p < 0.001). However, the PDL and device-related thrombosis at 45 days and 1 year were comparable between the two groups (37% vs. 23%, p = 0.24; 28% vs. 31%, p = 0.84; 2.1% vs. 1.4%, p = 0.50; 6.9% vs. 6.0%, p = 0.69, respectively). The 3-year cumulative incidence of ischemic stroke, all cardiovascular death, and all-cause death were comparable between the two groups (5.7% vs. 5.5%, log-rank p = 0.96; 7.7% vs. 8.9%, log-rank p = 0.34, 31.4% vs. 22.3%, log-rank p = 0.71, respectively). CONCLUSION: The angiographically detected residual trabeculation rate was 5.6%, and this population had a significantly higher prevalence of PDL at the procedure. However, the presence of residual trabeculation did not contribute to PDL or device-related thrombosis at follow-up or affect the clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Chatani et al. (2024) conducted a cohort in Atrial fibrillation (n=1,350). Angiographically detected residual trabeculation vs. No angiographically detected residual trabeculation was evaluated on Peri-device leak (PDL) at the procedure (p=<0.001). Angiographically detected residual trabeculation after WATCHMAN LAAC was associated with higher peri-device leak at the procedure but did not affect 3-year clinical outcomes.
Synapse has enriched 10 related papers. Consider them for comparative context: